Technology

Each treatment option OvaScience is developing utilizes the breakthrough discovery of EggPCSM cells – immature egg cells found inside the protective ovarian lining.

OvaScience’s proprietary technology platform leverages the breakthrough discovery of egg precursor (EggPCSM) cells. EggPC cells are immature egg cells found inside the protective ovarian lining that have the potential to be matured into new, fertilizable eggs. It was long believed a woman was born with a set number of eggs that die over time. The presence of EggPC cells changes that fundamental understanding about female biology, and opens up extraordinary possibilities to help women improve their fertility.

EggPC cells were first discovered by one of OvaScience’s scientific founders, Jonathan Tilly, Ph.D. Subsequent research demonstrated that EggPC cells exist in human ovaries and have the potential to develop into mature eggs, thereby replenishing a woman’s egg supply.

OvaScience’s EggPC technology platform is the foundation for each of our fertility treatments. To learn more about the application of our technology, visit our Treatments section.